MarginsXMarginsX
Home › Markets › Industrials › CBT

Cabot Corporation (CBT)

CBT trades on NYSE in Industrials, Major Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$70.92
-1.39% on the day
Market cap
$3.7B
Mid cap
Revenue · 2025
$3.7B
-7.0% on 2024
Net income · 2025
$331.0M
8.9% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-09-30, https://www.sec.gov/Archives/edgar/data/16040/000119312525292412/0001193125-25-292412-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-09-30.

Profile

FieldValue
TickerCBT on NYSE
SectorIndustrials
IndustryMajor Chemicals
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000016040
SEC industry codeMiscellaneous Chemical Products
Incorporated inDE

Financials · 2025

LineValue
Revenue$3.7B
Net income$331.0M
Operating income$621.0M
Net margin8.9%
Operating margin16.7%
Revenue growth-7.0%
Cash$258.0M
Total assets$3.8B
P/E (computed)11.1×
P/S (computed)1.0×

Warning signs

Cash runway
Cash-flow positive
$250.0M cash at June 30, 2026
Share count, 1 year
-3.0%
2025-07-31 to 2026-07-31 · -7.7% over 3 years
Going-concern doubt
No
10-Q filed August 4, 2026
Insider net buying, 12 months
-$19.6M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-08-04
Cash and burn$250.0M cash; operating cash flow $124.3M a quarter.Report 2026-06-30
Shares outstanding51,631,007 (2026-07-31); 53,203,624 a year earlier; 55,936,984 three years earlier.Cover page 2026-07-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2025-12-04
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $19.6M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-06-30
$982.0M$6.0M$75.0M$250.0M$1.3B$3.6B10-Q 2026-08-04
Q2 2026
2026-03-31
$904.0M$68.0M$77.0M$252.0M$1.3B$3.6B10-Q 2026-05-06
Q1 2026
2025-12-31
$849.0M$73.0M$126.0M$230.0M$1.1B$3.6B10-Q 2026-02-04
Q4 2025
2025-09-30
$899.0M$43.0M$219.0M$258.0M$1.1B$3.7B10-K 2025-11-24
Q3 2025
2025-06-30
$923.0M$101.0M$249.0M$239.0M$1.2B$3.8B10-Q 2026-08-04
Q2 2025
2025-03-31
$936.0M$94.0M$73.0M$213.0M$1.3B$3.9B10-Q 2026-05-06
Q1 2025
2024-12-31
$955.0M$93.0M$124.0M$183.0M$1.2B$4.0B10-Q 2026-02-04
Q4 2024
2024-09-30
$1.0B$137.0M$204.0M$223.0M$1.1B$4.0B10-K 2025-11-24

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22026-08-14
Latest annual report10-K2025-11-24
Latest quarterly / interim10-Q2026-08-04
Latest current report8-K2026-11-02
Latest proxyDEFA14A2026-01-27

Source: SEC EDGAR submissions feed, 1,005 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.2%
1 month-4.7%
3 months-16.6%
Year to date+8.5%
1 year+15.6%
From 52-week high-23.0%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Major Chemicals

TickerCompanyPriceDayMarket cap
AVNTAvient Corporation$43.97-1.54%$4.0B
VVVValvoline Inc.$34.25-1.07%$4.4B
WDFCWD-40 Company$226.01+1.17%$3.0B
PRMPerimeter Group Inc.$29.43+0.24%$4.8B
SXTSensient Technologies Corporation$114.59-1.81%$4.9B
KWRQuaker Houghton$152.07-2.16%$2.6B
MEOHMethanex Corporation$66.89-5.13%$5.2B
CECelanese Corporation$48.96-4.77%$5.4B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier